Analyst Consensus ?
ConsensusBuy55 ratings
Bullish3869.1%
Neutral1221.8%
Bearish59.1%
FN2 Earnings Intelligence
The Boeing Company complete analyst coverage
The Boeing Company (BA) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$210.45Current
$109Low
$234.31Average
$305High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 11, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Argus Research | Buy | Hold | Upgrade | Aug 11, 2026 |
| Tigress Financial | Buy | Buy | Maintain | Aug 6, 2026 |
| BNP Paribas | Outperform | Underperform | Upgrade | Aug 3, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 29, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 29, 2026 |
| Citigroup | Buy | Buy | Maintain | May 18, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Apr 23, 2026 |
| Freedom Broker | Buy | Buy | Maintain | Feb 6, 2026 |
| Jefferies | Buy | Buy | Maintain | Feb 2, 2026 |
| UBS | Buy | Buy | Maintain | Jan 28, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Jan 15, 2026 |
| Susquehanna | Positive | Positive | Maintain | Nov 12, 2025 |
| Freedom Capital Markets | Buy | Hold | Upgrade | Nov 3, 2025 |
| Vertical Research | Buy | Hold | Upgrade | Sep 8, 2025 |
| B of A Securities | Buy | Buy | Maintain | Aug 1, 2025 |
| Barclays | Overweight | Overweight | Maintain | Jul 29, 2025 |
| Redburn Atlantic | Buy | Neutral | Upgrade | Jun 27, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Jun 12, 2025 |
| Wells Fargo | Underweight | Underweight | Maintain | Apr 24, 2025 |
| TD Securities | Buy | Buy | Maintain | Apr 24, 2025 |
| Benchmark | Buy | Buy | Maintain | Apr 21, 2025 |
| Deutsche Bank | Buy | Buy | Maintain | Jan 2, 2025 |
| Baird | Outperform | Outperform | Maintain | Oct 24, 2024 |
| TD Cowen | Buy | Buy | Maintain | Oct 14, 2024 |
| Stifel | Buy | Buy | Maintain | Aug 1, 2024 |
| Northcoast Research | Sell | Neutral | Downgrade | Apr 17, 2024 |
| Melius Research | Hold | Buy | Downgrade | Apr 1, 2024 |
| Wolfe Research | Outperform | Outperform | Maintain | Mar 13, 2024 |
| Credit Suisse | Neutral | Neutral | Maintain | Apr 27, 2023 |
| Redburn Partners | Neutral | Neutral | Maintain | Nov 7, 2022 |
| Cowen & Co. | Outperform | Outperform | Maintain | Mar 7, 2022 |
| Berenberg | Hold | Hold | Maintain | Jun 15, 2021 |
| Canaccord Genuity | Buy | Hold | Upgrade | Mar 5, 2021 |
| Redburn | Sell | Neutral | Downgrade | Dec 17, 2020 |
| Alembic Global | Overweight | Neutral | Upgrade | Sep 28, 2020 |
| Seaport Global | Buy | Buy | Maintain | Jun 8, 2020 |
| Buckingham Research | Neutral | Neutral | Maintain | Feb 5, 2020 |
| Buckingham | Neutral | Neutral | Maintain | Feb 5, 2020 |
| CFRA | Buy | Hold | Upgrade | Jan 22, 2020 |
| Longbow Research | Underperform | Underperform | Maintain | Jan 7, 2020 |
| Bank of America | Neutral | Neutral | Maintain | Dec 23, 2019 |
| Citi | Buy | Buy | Maintain | Oct 24, 2019 |
| Argus | Hold | Buy | Downgrade | Mar 19, 2019 |
| Societe Generale | Buy | Hold | Upgrade | Apr 26, 2018 |
| Edward Jones | Buy | Hold | Upgrade | Feb 13, 2018 |
| Standpoint Research | Sell | Buy | Downgrade | Oct 26, 2016 |
| Stifel Nicolaus | Buy | Buy | Maintain | Feb 23, 2015 |
| Drexel Hamilton | Buy | Hold | Upgrade | May 22, 2014 |
| CRT Capital | Buy | Buy | Maintain | Feb 6, 2014 |
| Oppenheimer | Perform | Outperform | Downgrade | Nov 20, 2013 |
| Sterne Agee | Buy | Buy | Maintain | Sep 16, 2013 |
| Imperial Capital | In Line | In Line | Maintain | May 24, 2013 |
| BB&T Capital | Buy | Hold | Upgrade | Apr 26, 2013 |
| Early Bird Capital | Buy | Buy | Maintain | Jul 25, 2012 |
| DA Davidson | Neutral | Neutral | Maintain | Jul 25, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $210.45. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Argus Research | Analyst unavailable | $265 | $232.79 | +25.9% | Aug 11, 2026 |
| Tigress Financial | Ivan Feinseth | $305 | $234.28 | +44.9% | Aug 6, 2026 |
| RBC Capital | Analyst unavailable | $265 | $212.4 | +25.9% | Jul 29, 2026 |
| Robert W. Baird | Peter Arment | $300 | $221.56 | +42.6% | Jul 29, 2026 |
| BTG Pactual | Analyst unavailable | $260 | $217.11 | +23.5% | Jul 14, 2026 |
| Tigress Financial | Analyst unavailable | $295 | $222.22 | +40.2% | Apr 29, 2026 |
| Wolfe Research | Analyst unavailable | $275 | $233.86 | +30.7% | Apr 23, 2026 |
| Morgan Stanley | Analyst unavailable | $250 | $233.66 | +18.8% | Apr 23, 2026 |
| Jefferies | Analyst unavailable | $295 | $233.72 | +40.2% | Feb 1, 2026 |
| RBC Capital | Ken Herbert | $275 | $241.42 | +30.7% | Jan 28, 2026 |
| Morgan Stanley | Analyst unavailable | $245 | $240.54 | +16.4% | Jan 28, 2026 |
| UBS | Gavin Parsons | $285 | $244.56 | +35.4% | Jan 28, 2026 |
| Vertical Research | Robert Stallard | $281 | $244.56 | +33.5% | Jan 27, 2026 |
| Susquehanna | Analyst unavailable | $280 | $247.24 | +33.0% | Jan 15, 2026 |
| Bernstein | Douglas Harned | $298 | $242.61 | +41.6% | Jan 15, 2026 |
| Bernstein | Analyst unavailable | $277 | $230.02 | +31.6% | Jan 6, 2026 |
| Tigress Financial | Analyst unavailable | $275 | $216.21 | +30.7% | Dec 29, 2025 |
| New Street | Analyst unavailable | $257 | $200.54 | +22.1% | Dec 9, 2025 |
| BNP Paribas | Analyst unavailable | $150 | $189.63 | -28.7% | Nov 18, 2025 |
| Bernstein | Douglas Harned | $267 | $194.85 | +26.9% | Nov 14, 2025 |
| Susquehanna | Analyst unavailable | $255 | $195.21 | +21.2% | Nov 12, 2025 |
| Loop Capital Markets | Sergey Glinyanov | $223 | $201.02 | +6.0% | Nov 3, 2025 |
| UBS | Analyst unavailable | $275 | $213.58 | +30.7% | Oct 30, 2025 |
| Jefferies | Analyst unavailable | $255 | $215.81 | +21.2% | Sep 30, 2025 |
| Vertical Research | Robert Stallard | $270 | $230.53 | +28.3% | Sep 8, 2025 |
| UBS | Analyst unavailable | $280 | $225.84 | +33.0% | Jul 30, 2025 |
| Barclays | Analyst unavailable | $255 | $226.08 | +21.2% | Jul 29, 2025 |
| RBC Capital | Ken Herbert | $230 | $203.75 | +9.3% | Jun 12, 2025 |
| Morgan Stanley | Kristine Liwag | $200 | $203.75 | -5.0% | Jun 12, 2025 |
| Goldman Sachs | Noah Poponak | $212 | $214 | +0.7% | Jun 11, 2025 |
| Melius Research | Analyst unavailable | $204 | $180.9 | -3.1% | Mar 24, 2025 |
| Deutsche Bank | Scott Deuschle | $215 | $171.87 | +2.2% | Jan 2, 2025 |
| Bernstein | Douglas Harned | $169 | $152.98 | -19.7% | Oct 29, 2024 |
| Susquehanna | Charles Minervino | $200 | $157.06 | -5.0% | Oct 24, 2024 |
| Robert W. Baird | Peter Arment | $200 | $157.06 | -5.0% | Oct 24, 2024 |
| Wells Fargo | Matthew Akers | $109 | $159.88 | -48.2% | Oct 23, 2024 |
| Citigroup | Jason Gursky | $209 | $148.99 | -0.7% | Oct 15, 2024 |
| Deutsche Bank | Scott Deuschle | $195 | $152.89 | -7.3% | Oct 3, 2024 |
| Wolfe Research | Myles Walton | $210 | $156.3 | -0.2% | Sep 24, 2024 |
| Goldman Sachs | Noah Poponak | $202 | $156.3 | -4.0% | Sep 24, 2024 |
| Jefferies | Sheila Kahyaoglu | $240 | $153.29 | +14.0% | Sep 23, 2024 |
| Citigroup | Jason Gursky | $224 | $156.77 | +6.4% | Sep 16, 2024 |
| CFRA | Stewart Glickman | $151 | $156.77 | -28.2% | Sep 13, 2024 |
| Wolfe Research | Myles Walton | $215 | $162.77 | +2.2% | Sep 13, 2024 |
| Goldman Sachs | Noah Poponak | $232 | $161.02 | +10.2% | Sep 3, 2024 |
| Wells Fargo | Matthew Akers | $119 | $173.74 | -43.5% | Sep 3, 2024 |
| Bank of America Securities | Ronald Epstein | $200 | $174.96 | -5.0% | Aug 26, 2024 |
| Seaport Global | Richard Safran | $207 | $174.73 | -1.6% | Aug 23, 2024 |
| Bernstein | Douglas Harned | $207 | $169.95 | -1.6% | Aug 5, 2024 |
| UBS | Gavin Parsons | $240 | $191.42 | +14.0% | Jun 7, 2024 |
| Robert W. Baird | Peter Arment | $240 | $177.61 | +14.0% | Jun 3, 2024 |
| Barclays | David Strauss | $190 | $177.61 | -9.7% | Jun 3, 2024 |
| Bernstein | Douglas Harned | $215 | $177.61 | +2.2% | Jun 3, 2024 |
| Stifel Nicolaus | Bert Subin | $230 | $172.21 | +9.3% | May 23, 2024 |
| CFRA | Stewart Glickman | $147 | $172.21 | -30.1% | May 23, 2024 |
| Wolfe Research | Myles Walton | $220 | $174.33 | +4.5% | May 23, 2024 |
| Deutsche Bank | Scott Deuschle | $225 | $162.98 | +6.9% | Apr 25, 2024 |
| Goldman Sachs | Noah Poponak | $243 | $164.33 | +15.5% | Apr 25, 2024 |
| Stifel Nicolaus | Bert Subin | $240 | $164.33 | +14.0% | Apr 24, 2024 |
| Northcoast Research | Chris Olin | $140 | $170.55 | -33.5% | Apr 17, 2024 |
| RBC Capital | Ken Herbert | $215 | $167.82 | +2.2% | Apr 16, 2024 |
| Morgan Stanley | Kristine Liwag | $180 | $178.12 | -14.5% | Apr 10, 2024 |
| Stifel Nicolaus | Bert Subin | $260 | $178.12 | +23.5% | Apr 9, 2024 |
| Bernstein | Douglas Harned | $240 | $183.14 | +14.0% | Apr 8, 2024 |
| Jefferies | Analyst unavailable | $85 | $184.92 | -59.6% | Apr 3, 2024 |
| CFRA | Analyst unavailable | $164 | $191.95 | -22.1% | Mar 28, 2024 |
| UBS | Gavin Parsons | $250 | $191.41 | +18.8% | Mar 25, 2024 |
| Morgan Stanley | Kristine Liwag | $235 | $191.41 | +11.7% | Mar 25, 2024 |
| Vertical Research | Robert Stallard | $230 | $191.41 | +9.3% | Mar 25, 2024 |
| Susquehanna | Charles Minervino | $230 | $187.7 | +9.3% | Mar 21, 2024 |
| Barclays | David Strauss | $235 | $187.7 | +11.7% | Mar 21, 2024 |
| Deutsche Bank | Scott Deuschle | $240 | $187.7 | +14.0% | Mar 21, 2024 |
| Wolfe Research | Myles Walton | $260 | $182.35 | +23.5% | Mar 13, 2024 |
| RBC Capital | Ken Herbert | $260 | $184.24 | +23.5% | Mar 12, 2024 |
| Jefferies | Shelia Kahyaoglu | $300 | $184.24 | +42.6% | Mar 12, 2024 |
| Citigroup | Jason Gursky | $271 | $200.44 | +28.8% | Jan 31, 2024 |
| Deutsche Bank | Scott Deuschle | $270 | $217.71 | +28.3% | Nov 20, 2023 |
| Susquehanna | Charles Minervino | $270 | $209.76 | +28.3% | Sep 13, 2023 |
| Credit Suisse | Scott Deuschle | $220 | $210.26 | +4.5% | Apr 10, 2023 |
| RBC Capital | Ken Herbert | $225 | $207.09 | +6.9% | Feb 3, 2023 |
| Wells Fargo | Analyst unavailable | $240 | $206.69 | +14.0% | Jan 11, 2023 |
| J.P. Morgan | Analyst unavailable | $207 | $206.69 | -1.6% | Jan 11, 2023 |
| Morgan Stanley | Kristine Liwag | $220 | $208.57 | +4.5% | Jan 10, 2023 |
| J.P. Morgan | Analyst unavailable | $200 | $183.74 | -5.0% | Dec 12, 2022 |
| Wells Fargo | Analyst unavailable | $218 | $180.91 | +3.6% | Dec 8, 2022 |
| RBC Capital | Ken Herbert | $170 | $156.75 | -19.2% | Nov 3, 2022 |
| New Street | Sam Boughedda Ahead | $175 | $131.57 | -16.8% | Oct 11, 2022 |
| Morgan Stanley | Kristine Liwag | $233 | $127.51 | +10.7% | Sep 27, 2022 |
| Goldman Sachs | Noah Poponak | $281 | $169.87 | +33.5% | Aug 1, 2022 |
| Wells Fargo | Analyst unavailable | $210 | $156.09 | -0.2% | Jul 28, 2022 |
| RBC Capital | Ken Herbert | $200 | $144.66 | -5.0% | Jul 14, 2022 |
| RBC Capital | Analyst unavailable | $200 | $144.18 | -5.0% | Jul 14, 2022 |
| J.P. Morgan | Analyst unavailable | $188 | $143.09 | -10.7% | Jul 13, 2022 |
| Morgan Stanley | Kristine Liwag | $215 | $120.7 | +2.2% | May 22, 2022 |
| Susquehanna | Charles Minervino | $192 | $120.7 | -8.8% | May 21, 2022 |
| Vertical Research | Robert Stallard | $193 | $127.2 | -8.3% | May 15, 2022 |
| RBC Capital | Ken Herbert | $220 | $148.84 | +4.5% | May 1, 2022 |
| Robert W. Baird | Peter Arment | $245 | $148.84 | +16.4% | Apr 30, 2022 |
| Bernstein | Douglas Harned | $216 | $154.22 | +2.6% | Apr 29, 2022 |
| J.P. Morgan | Analyst unavailable | $190 | $152.22 | -9.7% | Apr 28, 2022 |
| Susquehanna | Analyst unavailable | $193 | $152.72 | -8.3% | Apr 28, 2022 |
| Wells Fargo | Analyst unavailable | $214 | $152.47 | +1.7% | Apr 28, 2022 |
| Cowen & Co. | Cai von Rumohr | $230 | $154.46 | +9.3% | Apr 28, 2022 |
| Vertical Research | Robert Stallard | $198 | $154.46 | -5.9% | Apr 27, 2022 |
| Benchmark Co. | Josh Sullivan | $250 | $171.05 | +18.8% | Apr 26, 2022 |
| Morgan Stanley | Kristine Liwag | $230 | $175.03 | +9.3% | Apr 11, 2022 |
| Robert W. Baird | Peter Arment | $306 | $192.83 | +45.4% | Mar 20, 2022 |
| Goldman Sachs | Noah Poponak | $307 | $178.39 | +45.9% | Mar 10, 2022 |
| Jefferies | Sheila Kahyaoglu | $270 | $206.45 | +28.3% | Feb 6, 2022 |
| Argus Research | John Eade | $210 | $200.24 | -0.2% | Jan 31, 2022 |
| Morgan Stanley | Kristine Liwag | $288 | $190.57 | +36.8% | Jan 29, 2022 |
| Wells Fargo | Matthew Akers | $250 | $189.75 | +18.8% | Jan 27, 2022 |
| Vertical Research | Robert Stallard | $234 | $194.27 | +11.2% | Jan 26, 2022 |
| Citigroup | Charles Armitage | $238 | $214.19 | +13.1% | Jan 20, 2022 |
| Bernstein | Douglas Harned | $259 | $225.01 | +23.1% | Jan 18, 2022 |
| Barclays | David E. Strauss | $225 | $211.34 | +6.9% | Jan 6, 2022 |
| Susquehanna | Charles Minervino | $243 | $211.34 | +15.5% | Jan 6, 2022 |
| Seaport Global | Richard Safran | $298 | $209.9 | +41.6% | Nov 22, 2021 |
| Credit Suisse | Robert Spingarn | $265 | $217.15 | +25.9% | Jul 20, 2021 |
| Capital One Financial | Jonathan Raviv | $240 | $234.82 | +14.0% | May 21, 2021 |
Track every rating change on BA the moment it posts. Free to start.
Start free